Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX)

Clinical and Experimental Immunology

Volumn 137, Issue 2, 2004, Pages 373-378

  Bakke, A C ^a,b   Purtzer, M Z ^a   Wildin, R S ^b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c INSTITUT PASTEUR   (France)

Author keywords

Apoptosis; Flow cytometry; Immunodeficiency diseases; Regulatory T cells; x linked

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CD71 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR;

ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIRTH; CASE REPORT; CLINICAL FEATURE; COLITIS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FLOW CYTOMETRY; HUMAN; IMMUNE DYSREGULATION POLYENDOCRINOPATHY ENTEROPATHY X LINKED SYNDROME; IMMUNOLOGICAL TECHNIQUE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; LYMPHOCYTE; MALE; MEDICAL EXAMINATION; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE INJURY;

FOLLOW-UP STUDIES; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNOPHENOTYPING; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; MALE; POLYENDOCRINOPATHIES, AUTOIMMUNE; PROTEIN-LOSING ENTEROPATHIES; SYNDROME; T-LYMPHOCYTE SUBSETS;

EID: 3543045638     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02537.x     Document Type: Article

References (25)

1. Wildin RS, Smyk-Pearson SK, Filipovich AH. Clinical and molecular features of the immuno-dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002; 39:537-5.
2. Powell B, Buist N, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 1982; 100:731-7.
3. Bennett CL, Yoshioka R, Kiyosawa H, Barker DF, Fain PR, Shigeoka AO, Chance PF. X-linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3. Am J Hum Genet 2000; 66:461-8.
4. Wildin RS, Ramsdell F, Peake J et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27:18-20.
5. Bennett CL, Christie J, Ramsdell F et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of Foxp3. Nat Genet 2001; 27:20-1.
6. Bennett CL, Brunkow ME, Ramsdell F et al. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome. Immunogenetics 2001; 53:435-9.
7. Stromberg E, Lundgren A, Edeto A, Lundine S, Svennerholm AM, Landholt C. Increased frequency of activated T-cells in the Helobacter pylori-infected antrum and duodenum. FEMS Immunol Med Microbiol 2003; 36:150-08.
8. Clark LB, Appleby MW, Brunkow ME, Wilkinson JE, Ziegler SF, Ramsdell F. Cellular and molecular characterization of the scurfy mouse mutant. J Immunol 1999; 162:2546-54.
9. Godfrey VL, Wilkinson JE, Russell LB. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am J Pathol 1991; 138:1379-87.
10. Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27:68-73.
11. Blair PJ, Bultman SJ, Haas JC, Rouse BT, Wilkinson JE, Godfrey VL. CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol 1994; 153:3764-74.
12. Patel DD. Escape from tolerance in the human X-linked autoimmunity-allergic dysregulation syndrome and the Scurfy mouse. J Clin Invest 2001; 107:155-7.
13. Zahorsky-Reeves JL, Wilkinson JE. The murine mutation scurfy (sf) results in an antigen-dependent lymphoproliferative disease with altered T cell sensitivity. Eur J Immunol 2001; 31:196-204.
14. Hori S, Nomura T, Sakaguchi S, Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61.
15. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function on CD4+CD25+ regulatory T cells. Nature Immunol 2003; 4:330-6.
16. Khattri R, Kasprowicz D, Cox T, Mortrud M, Appleby MW, Brunkow ME, Ziegler SF, Ramsdell F. The amount of scrufin protein determines peripheral T cell number and responsiveness. J Immunol 2001; 167:6312-20.
17. Smyk-Pearson SK, Bakke AC, Held PK, Wildin RS. Rescue of the autoimmune scurry mouse by partial bone marrow transplantation or by injection with T-enriched splenocytes. Clin Exp Immunol 2003; 133:193-9.
18. Baud O, Goulet O, Canioni D et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001; 344:1758-62.
19. Baescher-Allan C, Viglietta V. Hafler DA Human CD4+CD25+ Regualtory T cells. Semin Immunolgy 2004; 16:89-97.
20. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995; 3:521-30.
21. YuA, Zhou J, Marten N, Bergmann CC, Mammolenti M, Levy RB, Malek TR. Efficient induction of primary and secondary T cell-dependent immune responses in vivo in the absence of functional IL-2 and IL-15 receptors. J Immunol 2003; 170:236-42.
22. Sharfe N, Dadi HK, Shahar M, Roifman CM. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 1997; 94:3168-71.
23. Almeida AR, Legrand N, Papiernik M, Freitas AA. Homeostasis of peripheral CD4+ T cells. IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 2002; 169:4850-60.
24. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 2001; 166:7282-9.
25. Gambineri E, Torgerson TR, Ochs HD. Immune deregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations in FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 15:430-5.